Clinical Practice of Adalimumab and Infliximab Biosimilar Treatment in Adult Patients With Crohn's Disease (vol 27, pg 106, 2021)

被引：0
|
作者：
Daneses, Silvio [1 ,2 ,3 ]
机构：
[1] Humanitas Clin & Res Ctr IRCCS, Dept Gastroenterol, IBD Ctr, Rozzano, Italy
[2] Humanitas Univ, Dept Biomed Sci, Milan, Italy
[3] Humanitas Clin & Res Ctr, Dept Gastroenterol, IBD Ctr, Milan, Italy
来源：
JOURNAL OF ANIMAL SCIENCE | 2022年 / 100卷 / 09期
关键词：
D O I：
暂无
中图分类号：
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号：
0905 ;
摘要：
引用
收藏
页码：1367 / 1367
页数：1
相关论文
共 50 条
  • [41] FACTORS INFLUENCING MUCOSAL HEALING IN CROHN'S DISEASE DURING INFLIXIMAB TREATMENT IN CLINICAL PRACTICE
    Tursi, A.
    Elisei, W.
    Giorgetti, G.
    Penna, A.
    Lecca, P. G.
    Di Cesare, L.
    Brandimarte, G.
    DIGESTIVE AND LIVER DISEASE, 2011, 43 : S211 - S211
  • [42] INFLIXIMAB ORIGINATOR, INFLIXIMAB BIOSIMILAR AND ADALIMUMAB ARE EQUALLY EFFECTIVE AND SAFE IN ULCERATIVE COLITIS AND CROHN'S DISEASE - A REAL-LIFE COHORT STUDY
    Barberio, B.
    Zingone, F.
    D'Inca, R.
    Rovigo, L.
    Marinelli, C.
    Massimi, D.
    Gubbiotti, A.
    Ghisa, M.
    Lorenzon, G.
    Savarino, E.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : S130 - S131
  • [43] Dose Escalation of Adalimumab (Humira®) in Patients with Crohn's Disease in Routine Clinical Practice in Quebec
    Monfared, Amir Abbas Tahami
    Fan, Tao
    Sen, Shuvayu
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S180 - S180
  • [44] Adalimumab for Crohn's disease in clinical practice at an academic medical center: the first 118 patients
    Swoger, Jason M.
    Loftus, Edward V.
    Pardi, Darrell S.
    Kane, Sunanda V.
    Tremaine, William J.
    Xiong, Yuning
    Hanson, Karen A.
    Harmseri, William S.
    Zinsmeister, Alan R.
    Sandborn, William J.
    GASTROENTEROLOGY, 2008, 134 (04) : A662 - A662
  • [45] Adalimumab safety in patients with Crohn's Disease and previous exposure to infliximab: CHOICE trial
    Lichuger, Simon
    Binion, David G.
    Wolf, David C.
    Present, Daniel H.
    Lomax, Kathleen G.
    Kent, Jeffrey D.
    Cardoso, Alexandra T.
    Lau, Winnie
    GASTROENTEROLOGY, 2008, 134 (04) : A489 - A489
  • [46] Adalimumab vs Infliximab in Pediatric Patients With Crohn's Disease: A Propensity Score Analysis and Predictors of Treatment Escalation
    Bronsky, Jiri
    Copova, Ivana
    Kazeka, Denis
    Lerchova, Tereza
    Mitrova, Katarina
    Pospisilova, Kristyna
    Sulovcova, Miroslava
    Zarubova, Kristyna
    Hradsky, Ondrej
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2022, 13 (05)
  • [47] Clinical effects of adalimumab treatment with concomitant azathioprine in Japanese Crohn's disease patients
    Kumi Ishida
    Takuya Inoue
    Kaori Fujiwara
    Taisuke Sakanaka
    Ken Narabayashi
    Sadaharu Nouda
    Toshihiko Okada
    Kazuki Kakimoto
    Takanori Kuramoto
    Ken Kawakami
    Yosuke Abe
    Toshihisa Takeuchi
    Mitsuyuki Murano
    Satoshi Tokioka
    Eiji Umegaki
    Kazuhide Higuchi
    World Journal of Gastroenterology, 2013, (17) : 2676 - 2682
  • [48] Clinical effects of adalimumab treatment with concomitant azathioprine in Japanese Crohn's disease patients
    Ishida, Kumi
    Inoue, Takuya
    Fujiwara, Kaori
    Sakanaka, Taisuke
    Narabayashi, Ken
    Nouda, Sadaharu
    Okada, Toshihiko
    Kakimoto, Kazuki
    Kuramoto, Takanori
    Kawakami, Ken
    Abe, Yosuke
    Takeuchi, Toshihisa
    Murano, Mitsuyuki
    Tokioka, Satoshi
    Umegaki, Eiji
    Higuchi, Kazuhide
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (17) : 2676 - 2682
  • [49] An open label study of adalimumab in Crohn's disease patients with a loss of response to infliximab
    Anwar, Malik
    O'Sullivan, Maria
    Ryan, Barbara
    Breslin, Niall
    O'Connor, Humphrey
    O'Morain, Colm
    GASTROENTEROLOGY, 2006, 130 (04) : A662 - A662
  • [50] OUTCOMES OF THE USE OF INFLIXIMAB AND ADALIMUMAB IN PATIENTS WITH CROHN'S DISEASE AT A DISTRICT GENERAL HOSPITAL
    Lane, C.
    Ramakrishnan, S.
    Dougherty, J.
    GUT, 2014, 63 : A70 - A70
12345